Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AADI
DateTimeSourceHeadlineSymbolCompany
06/03/202411:26AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
05/29/20243:05PMPR Newswire (US)Aadi Bioscience to Participate in the Jefferies Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
05/23/20244:30PMPR Newswire (US)Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:AADIAadi Bioscience Inc
05/08/20243:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AADIAadi Bioscience Inc
05/08/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
05/08/20247:00AMPR Newswire (US)Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
05/01/20247:01AMPR Newswire (US)Aadi Bioscience to Report First Quarter 2024 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
04/09/20247:00AMPR Newswire (US)Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:AADIAadi Bioscience Inc
03/17/20247:00AMPR Newswire (US)Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)NASDAQ:AADIAadi Bioscience Inc
03/13/20247:00AMPR Newswire (US)Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
03/06/20247:00AMPR Newswire (US)Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate UpdateNASDAQ:AADIAadi Bioscience Inc
03/05/20243:30PMPR Newswire (US)Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:AADIAadi Bioscience Inc
03/04/20246:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
03/04/20246:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
03/04/20246:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
03/01/20243:08PMPR Newswire (US)Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComaNASDAQ:AADIAadi Bioscience Inc
03/01/202412:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
02/26/20243:05PMPR Newswire (US)Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
02/12/20244:21PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AADIAadi Bioscience Inc
02/12/20244:16PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AADIAadi Bioscience Inc
02/02/20244:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
01/26/20243:05PMPR Newswire (US)Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers SymposiumNASDAQ:AADIAadi Bioscience Inc
01/19/20243:05PMPR Newswire (US)Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers SymposiumNASDAQ:AADIAadi Bioscience Inc
01/02/20246:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
12/14/20234:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
12/14/20233:05PMPR Newswire (US)Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating AlterationsNASDAQ:AADIAadi Bioscience Inc
12/07/20233:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
12/05/20235:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
12/01/202310:37AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
11/08/20233:54PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AADIAadi Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:AADI